Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

August, 2007:

Merck submits modified niacin to FDA

Rx data firms sue Maine, Vermont

Beers pushes pharma to stand up and fight critics

Change at top for producer of physician confabs

MM&M Awards tickets now on sale

Product News

People News

Novartis BP drug sees approval in Europe

Perils of patches underappreciated, says LA Times

FDA approves Teva's generic Famvir application

AMA launches health insurance fix blitz

Move over lithium; FDA sanctions use of Risperdal in teens

Pfizer taps CFO with turnaround experience

FDA to study DTC ads

Conference to explore online health communities

Product news

People news

Account wins

Amgen seeks to ease investor concerns as staff cuts loom

New approval for drug gives Novartis excuse to up promotion

Quick and dirty polls need vetting, big research firms say

Lipitor patent reissue rejected, for now

Warfarin label change advises on genetic factors

Detailing spend far outweighs DTC: Study

Amgen to trim workforce by up to 14%

'Metro' fires Kalan for declaring newspapers dead

Avoiding the DDMAC letter: Advice from a Pfizer counselor

Timing of FDA notice on diabetes meds leads to confusion

Moravick takes over as Ketchum healthcare head

Monroid takes the helm at Euro&s Metamax

Pfizer unveils new consumer Web site

Novartis withdraws Prexige in Australia

Product news

People news

Company news

Pipeline problems for Wyeth

Lilly may extend grant disclosure policy globally

FDA rejects new use for GSK&s Advair

Cipla quarrels with AIDS activists on price of drug

ImClone appoints former J&J exec as CEO

J&J sues Red Cross over use of symbol

FDA eyes Nexium, Prilosec for heart risks with early communication

Key advisor: FDA should hold diabetes drugs to different standard

Nektar to team with Bayer on inhaled antibiotic

Company news

People news

Product news

Last chance to vent (or gush) about your job…

Medical Advertising Hall of Fame seeks nominations

Takeda seeing more patients name-check Rozerem; will sales follow?

Have you checked the list of finalists for the MM&M Awards 2007?

FDA approves Pfizer's maraviroc HIV treatment

CME regulator issues plan for shoring up oversight

House OKs reimportation legislation

Sales reps& bias lawsuit against Novartis to move forward

Second approvable letter for GSK and Pozen migraine treatment

PRI offers digital version of MPR

Publisher combats ad spend drought

Film to educate RN prescribers

Senate pushes national gift registry

Will physicians use the iPhone for CME?

GSK ranks 7th in consumer ads

Physicians back DTC ban

Cord blood ads have hypnotic effect

Santarus reps pushing Naprelan

Ex-Abbott reps sue for overtime pay

Vyvanse prepares to lead ADHD class

Reps claim FDA met with industry more than other groups

Public Citizen files petition with FDA

KV Pharmaceutical e-mail alert overstated drug efficacy

FDA: Enzon's Abelcet makes unsubstantiated superiority claims

Penn. paying for counter-detailing

Users blast availability of MedGuides

Sens. introduce follow-on biologics bill

Drug firms slack on DTC guidelines

Gottlieb floats third class of drugs idea—again

As I see it

Communicating the Science

Specialization in the digital realm

Vantage Point

'Epi' tools aim to ease forecasting

Harris: open architecture ups research visibility

PR View by Melissa Hill

MWW hires da Costa as vice president

InVentiv bets on PR with Chandler Chicco pickup

Web Watch

MBC veteran leaves Digitas Health

Patients prefer promo in online video, visual form

Follow-on drugs, not hangers-on, says study

Antidote

How to recycle your skills

Headliner: Daniel Palestrant of Sermo

New Life for an Old Brand

Medical Education

Designs from Experience

Medical Education Review 2007: Med Ed Mettle

Sanofi-Aventis has room for sales force reductions: Spek

Med Ed Report: CME's Open Gesture

J&Js Alza and Scios units to cut jobs

J&J assigns ads duties on several OTC health brands

Three NY Dems strike measures inhibiting consumer ads

HealthiNation partners with dLife

Consumer advertising of Rx drugs up, newspaper ads down

PDI inks deal with 'top-five' pharma company

HealthEd adds new members to its staff

Publicis Selling Solutions hires Hopkins as SVP

Wasti joins The Patient Marketing Group

Krouse named VP, director of healthcare for Emerging Media Lab

Quadrant HealthCom hires Danielsen and Saunders

FDA panel recommends Tysabri as Crohn's treatment

Communications Media Inc. launches online newsletter

Consumer ad spend is bright spot for media owners

PTR Educational Consultants publishes tools for providers

Wang named director for MedPoint Communications

Univ. of Pitt. Medical Center extends limits of gift policy

Carlat launches The Carlat Psychiatry Blog

Bellande named president of CME Enterprise

  

Web Exclusive

What NOT to say to an MS Patient

Dorothy Wetzel June 07, 2013

It is often hard to find the right words when talking to a patient, friend or family member with MS. Even with training and awareness of the disease, we often blurt out something we think is innocuous only to find out later that we have deeply offended. The Health Activists that Extrovertic spoke to had some suggestions for having positive conversations with someone with MS.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
 

© 2013 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions